Emtricitabine
Back to searchMolecule Structure
Scientific Name
Emtricitabine
Description of the Drug
Emtricitabine is a nucleoside reverse transcriptase inhibitor used for the treatment and prophylaxis of HIV.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00879
http://www.drugbank.ca/drugs/DB00879
Brand Name(s)
Emtriva
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Cipla Ltd, Teva Pharmaceuticals Usa Inc, Apotex Inc, Macleods Pharmaceuticals Ltd, Laurus Labs Ltd, Hetero Labs Ltd Unit Iii, Aurobindo Pharma Ltd, Gilead Sciences Inc, Gilead Sciences Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL39708 | ||
| PharmGKB | PA10069 | ||
| Human Metabolome Database | HMDB0015017 | ||
| DrugBank | DB00879 | ||
| PubChem: Thomson Pharma | 14847619 | 14749730 | |
| PubChem | 60877 | ||
| Mcule | MCULE-7141046266 | ||
| LINCS | LSM-45730 | ||
| Nikkaji | J523.685A | ||
| PDBe | ETV | ||
| BindingDB | 50107843 | ||
| EPA CompTox Dashboard | DTXSID0040129 | ||
| DrugCentral | 1003 | ||
| Brenda | 18182 | 135620 | |
| ChemicalBook | CB71378240 | CB5266199 | |
| Guide to Pharmacology | 11244 | ||
| rxnorm | EMTRICITABINE | BIKTARVY | EMTRIVA |
| PubChem: Drugs of the Future | 12014747 | ||
| KEGG Ligand | C12599 | ||
| ChEBI | 31536 | ||
| ZINC | ZINC000003629271 |
